These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 24553344)

  • 1. Thromboembolic complications with Pipeline Embolization Device placement: impact of procedure time, number of stents and pre-procedure P2Y12 reaction unit (PRU) value.
    Tan LA; Keigher KM; Munich SA; Moftakhar R; Lopes DK
    J Neurointerv Surg; 2015 Mar; 7(3):217-21. PubMed ID: 24553344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pre-procedure P2Y12 reaction units value predicts perioperative thromboembolic and hemorrhagic complications in patients with cerebral aneurysms treated with the Pipeline Embolization Device.
    Delgado Almandoz JE; Crandall BM; Scholz JM; Fease JL; Anderson RE; Kadkhodayan Y; Tubman DE
    J Neurointerv Surg; 2013 Nov; 5 Suppl 3():iii3-10. PubMed ID: 23314576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P2Y12 hyporesponse (PRU>200) is not associated with increased thromboembolic complications in anterior circulation Pipeline.
    Bender MT; Lin LM; Colby GP; Lubelski D; Huang J; Tamargo RJ; Coon AL
    J Neurointerv Surg; 2017 Oct; 9(10):978-981. PubMed ID: 27599997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of antiplatelet therapy on thromboembolism after flow diversion with the pipeline embolization device.
    Heller RS; Dandamudi V; Lanfranchi M; Malek AM
    J Neurosurg; 2013 Dec; 119(6):1603-10. PubMed ID: 23971953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P2Y12 Reaction Units: Effect on Hemorrhagic and Thromboembolic Complications in Patients With Cerebral Aneurysms Treated With the Pipeline Embolization Device.
    Daou B; Starke RM; Chalouhi N; Barros G; Tjoumakaris S; Rosenwasser RH; Jabbour P
    Neurosurgery; 2016 Jan; 78(1):27-33. PubMed ID: 26571145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Procedural complexity independent of P2Y12 reaction unit (PRU) values is associated with acute in situ thrombosis in Pipeline flow diversion of cerebral aneurysms.
    Jiang B; Bender MT; Westbroek EM; Campos JK; Lin LM; Xu R; Tamargo RJ; Huang J; Colby GP; Coon AL
    Stroke Vasc Neurol; 2018 Sep; 3(3):169-175. PubMed ID: 30294473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Last-recorded P2Y12 reaction units value is strongly associated with thromboembolic and hemorrhagic complications occurring up to 6 months after treatment in patients with cerebral aneurysms treated with the pipeline embolization device.
    Delgado Almandoz JE; Crandall BM; Scholz JM; Fease JL; Anderson RE; Kadkhodayan Y; Tubman DE
    AJNR Am J Neuroradiol; 2014 Jan; 35(1):128-35. PubMed ID: 23828107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concurrent use of the Pipeline Embolization Device and coils for intracranial aneurysms: technique, safety, and efficacy.
    Nossek E; Chalif DJ; Chakraborty S; Lombardo K; Black KS; Setton A
    J Neurosurg; 2015 Apr; 122(4):904-11. PubMed ID: 25658781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroform intracranial stenting for aneurysms using simple and multi-stent technique is associated with low risk of magnetic resonance diffusion-weighted imaging lesions.
    Heller RS; Dandamudi V; Calnan D; Malek AM
    Neurosurgery; 2013 Oct; 73(4):582-90; discussion 590-1. PubMed ID: 23787881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early angiographic signs of acute thrombus formation following cerebral aneurysm treatment with the Pipeline embolization device.
    Patel A; Miller TR; Shivashankar R; Jindal G; Gandhi D
    J Neurointerv Surg; 2017 Nov; 9(11):1125-1130. PubMed ID: 27770038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defining a Clopidogrel Response Cut-Off Value Using Light Transmission Aggregometry Before Pipeline Embolization of Unruptured Intracranial Aneurysms.
    Adeeb N; Gupta R; Schneider AM; Leadon M; Enriquez A; Griessenauer CJ; Salem M; Alturki A; Schmalz P; Ogilvy CS; Thomas AJ; Moore JM
    World Neurosurg; 2018 May; 113():e146-e152. PubMed ID: 29425984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. One and done? The effect of number of Pipeline embolization devices on aneurysm treatment outcomes.
    Waqas M; Vakharia K; Gong AD; Rai HH; Wack A; Fayyaz N; Snyder KV; Davies JM; Siddiqui AH; Levy EI
    Interv Neuroradiol; 2020 Apr; 26(2):147-155. PubMed ID: 31766960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of Platelet Function Testing Before Pipeline Embolization Device Placement: A Multicenter Cohort Study.
    Adeeb N; Griessenauer CJ; Foreman PM; Moore JM; Shallwani H; Motiei-Langroudi R; Alturki A; Siddiqui AH; Levy EI; Harrigan MR; Ogilvy CS; Thomas AJ
    Stroke; 2017 May; 48(5):1322-1330. PubMed ID: 28411263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Very late ischemic complications in flow-diverter stents: a retrospective analysis of a single-center series.
    Guédon A; Clarençon F; Di Maria F; Rosso C; Biondi A; Gabrieli J; Rojas P; Chiras J; Sourour N
    J Neurosurg; 2016 Oct; 125(4):929-935. PubMed ID: 26824382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silent ischemic events after Pipeline embolization device: a prospective evaluation with MR diffusion-weighted imaging.
    Brasiliense LB; Stanley MA; Grewal SS; Cloft HJ; Sauvageau E; Lanzino G; Miller D; Kallmes DF; Hanel R
    J Neurointerv Surg; 2016 Nov; 8(11):1136-1139. PubMed ID: 26747877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of thromboelastography to tailor dual-antiplatelet therapy in patients undergoing treatment of intracranial aneurysms with the Pipeline embolization device.
    McTaggart RA; Choudhri OA; Marcellus ML; Brennan T; Steinberg GK; Dodd RL; Do HM; Marks MP
    J Neurointerv Surg; 2015 Jun; 7(6):425-30. PubMed ID: 24739599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet Function Testing with a VerifyNow-Directed Personalized Antiplatelet Strategy and Associated Rates of Thromboembolic Complications After Pipeline Embolization for Complex Cerebral Aneurysms.
    Neyens R; Donaldson C; Andrews C; Kellogg R; Spiotta A
    World Neurosurg; 2020 Jun; 138():e674-e682. PubMed ID: 32194270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flow diversion with the pipeline embolization device for patients with intracranial aneurysms and antiplatelet therapy: A systematic literature review.
    Texakalidis P; Bekelis K; Atallah E; Tjoumakaris S; Rosenwasser RH; Jabbour P
    Clin Neurol Neurosurg; 2017 Oct; 161():78-87. PubMed ID: 28863286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age-related outcomes following intracranial aneurysm treatment with the Pipeline Embolization Device: a subgroup analysis of the IntrePED registry.
    Brinjikji W; Kallmes DF; Cloft HJ; Lanzino G
    J Neurosurg; 2016 Jun; 124(6):1726-30. PubMed ID: 26544776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early postmarket results after treatment of intracranial aneurysms with the pipeline embolization device: a U.S. multicenter experience.
    Kan P; Siddiqui AH; Veznedaroglu E; Liebman KM; Binning MJ; Dumont TM; Ogilvy CS; Gaughen JR; Mocco J; Velat GJ; Ringer AJ; Welch BG; Horowitz MB; Snyder KV; Hopkins LN; Levy EI
    Neurosurgery; 2012 Dec; 71(6):1080-7; discussion 1087-8. PubMed ID: 22948199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.